Severe chronic plaque psoriasis paediatric - ustekinumab - initial, change, recommencement or demonstration of response authority application form (PB320)

Use this form to apply for initial, change, recommencement or demonstration PBS-subsidised treatment with ustekinumab for patients under 18 years with severe chronic plaque psoriasis.

Page last updated: 1 May 2024.
QC 55530